Oncopeptides AB (OM:ONCO) Price Target Decreased by 45.99% to 2.86

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA Stocks Oncopeptides AB (OM:ONCO) Price Target Decreased by 45.99% to 2.86 February 28, 2026 — 08:08 am EST Written by George Maybach for Fintel-> The average one-year price target for Oncopeptides AB (OM:ONCO) has been revised to 2,86 kr / share. This is a decrease of 45.99% from the prior estimate of 5,29 kr dated February 1, 2026. The price target is an average of many targets provided by analysts. The latest targets range from a low of 2,83 kr to a high of 2,94 kr / share. The average price target represents an increase of 60.45% from the latest reported closing price of 1,78 kr / share. What is the Fund Sentiment? There are 1 funds or institutions reporting positions in Oncopeptides AB. This is unchanged over the last quarter. Average portfolio weight of all funds dedicated to ONCO is 0.00%, an increase of 0.00%. Total shares owned by institutions decreased in the last three months by 0.00% to 8K shares. What are Other Shareholders Doing? SPEU - SPDR(R) Portfolio Europe ETF holds 8K shares representing 0.00% ownership of the company. In its prior filing, the firm reported owning 14K shares , representing a decrease of 69.56%. The firm decreased its portfolio allocation in ONCO by 4.16% over the last quarter. Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.Click to Learn MoreThis story originally appeared on Fintel. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags Stocks Fintel Fintel is a leading provider of financial data and insights for intelligent, data-driven investors. With coverage of over 75,000 listed companies on all major stock exchanges, Fintel has the most comprehensive coverage of global equities at prices individual investors can afford. Find out what Retail is Buying with our Retail Ownership and Funds Flow Leaderboard-> Check out our Gamma Squeeze Leaderboard for High-Conviction Trading Ideas-> For Best Dividend Investments, Check out our Dividend Leaderboard-> More articles by this source-> More Related Articles This data feed is not available at this time. Data is currently not available • Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.